Numelvi Tablets 4.8 mg for Itch relief for Small Dogs

NUMELVI is a once-daily tablet that serves as a first-line treatment and is the sole second-generation Janus kinase (JAK) inhibitor approved for alleviating pruritus linked to allergic dermatitis, such as atopic dermatitis, as well as addressing the clinical signs of atopic dermatitis in dogs. Numelvi – the innovative solution for itch relief – is a novel option for managing canine allergic dermatitis, emphasizing selectivity, safety, and ease of use. Active Ingredients Numelvi includes Atinvicitinib. Indications For alleviating pruritus associated with allergic dermatitis, including atopic dermatitis in dogs. For addressing inflammation and clinical signs of atopic dermatitis in dogs.
Expires on 28 Feb 2029